DK2603219T3 - Kombination af GLYT1-forbindelse med antipsykotika - Google Patents

Kombination af GLYT1-forbindelse med antipsykotika

Info

Publication number
DK2603219T3
DK2603219T3 DK11739097.1T DK11739097T DK2603219T3 DK 2603219 T3 DK2603219 T3 DK 2603219T3 DK 11739097 T DK11739097 T DK 11739097T DK 2603219 T3 DK2603219 T3 DK 2603219T3
Authority
DK
Denmark
Prior art keywords
glyt1
antipsychotics
compound
combination
glyt1 compound
Prior art date
Application number
DK11739097.1T
Other languages
English (en)
Inventor
Daniela Alberati
Jean-Luc Moreau
Joseph G Wettstein
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44512856&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2603219(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK2603219T3 publication Critical patent/DK2603219T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK11739097.1T 2010-08-09 2011-08-05 Kombination af GLYT1-forbindelse med antipsykotika DK2603219T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10172316 2010-08-09
PCT/EP2011/063533 WO2012019970A1 (en) 2010-08-09 2011-08-05 Combination of glyt1 compound with antipsychotics

Publications (1)

Publication Number Publication Date
DK2603219T3 true DK2603219T3 (da) 2014-10-13

Family

ID=44512856

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11739097.1T DK2603219T3 (da) 2010-08-09 2011-08-05 Kombination af GLYT1-forbindelse med antipsykotika

Country Status (29)

Country Link
US (1) US20120035156A1 (da)
EP (1) EP2603219B1 (da)
JP (1) JP2013533297A (da)
KR (1) KR101455947B1 (da)
CN (1) CN103068388A (da)
AR (1) AR084401A1 (da)
AU (1) AU2011288536B2 (da)
BR (1) BR112013003068A2 (da)
CA (1) CA2803656A1 (da)
CL (1) CL2013000378A1 (da)
CR (1) CR20130027A (da)
CY (1) CY1115886T1 (da)
DK (1) DK2603219T3 (da)
EA (1) EA201291477A1 (da)
EC (1) ECSP13012431A (da)
ES (1) ES2521596T3 (da)
HR (1) HRP20141199T1 (da)
MA (1) MA34457B1 (da)
MX (1) MX2013001166A (da)
NZ (1) NZ604891A (da)
PE (1) PE20131100A1 (da)
PH (1) PH12013500078A1 (da)
PL (1) PL2603219T3 (da)
PT (1) PT2603219E (da)
SG (1) SG187108A1 (da)
SI (1) SI2603219T1 (da)
TW (1) TW201211019A (da)
WO (1) WO2012019970A1 (da)
ZA (1) ZA201300434B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20230747T1 (hr) 2011-09-08 2024-01-05 Sage Therapeutics, Inc. Neuroaktivni steroidi, pripravci i njihova uporaba
SMT201800657T1 (it) 2013-03-13 2019-01-11 Sage Therapeutics Inc Steroidi neuroattivi e loro metodi di utilizzo
CA2924016A1 (en) * 2013-12-03 2015-06-11 F. Hoffmann-La Roche Ag Pharmaceutical composition
CN106687626B (zh) * 2014-04-30 2021-01-26 宇凤·简·曾 作为d-氨基酸氧化酶抑制剂的已知化合物的用途
WO2015195967A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
SG11201702799UA (en) * 2014-10-07 2017-05-30 Sage Therapeutics Inc Neuroactive compounds and methods of use thereof
AU2016289965B2 (en) 2015-07-06 2021-09-09 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
MX382122B (es) 2015-07-06 2025-03-13 Sage Therapeutics Inc Oxiesteroles y metodos de uso de los mismos.
PL3319611T3 (pl) 2015-07-06 2021-07-12 Sage Therapeutics, Inc. Oksysterole i sposoby ich stosowania
EP3436022B1 (en) 2016-04-01 2022-03-09 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
US10752653B2 (en) 2016-05-06 2020-08-25 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
WO2018009867A1 (en) 2016-07-07 2018-01-11 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
PT3519422T (pt) 2016-09-30 2022-12-05 Sage Therapeutics Inc Oxisteróis substituídos em c7 e métodos como moduladores nmda
DK4105223T3 (da) 2016-10-18 2025-07-07 Sage Therapeutics Inc Oxysteroler og fremgangsmåder til anvendelse deraf
CA3041088C (en) 2016-10-18 2024-05-21 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
CN107469087A (zh) * 2017-09-10 2017-12-15 孙永丽 用于治疗精神病的制剂
MX2020004975A (es) * 2017-11-14 2020-08-24 Sk Biopharmaceuticals Co Ltd Mezcla que contiene compuesto de carbamato para prevencion, mitigacion o tratamiento de esquizofrenia.
KR20220125326A (ko) * 2020-01-09 2022-09-14 디스크 메디슨, 인크. 적혈구형성 프로토포르피린증, x-연계된 프로토포르피린증, 또는 선천성 적혈구 조혈포르피린증을 글리신 운반 억제제로 치료하는 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS53252B (sr) * 2003-08-11 2014-08-29 F.Hoffmann-La Roche Ag. Piperazin sa or-supstituisanom fenil grupom i njihova upotreba kao inhibitora glyt1
WO2006000222A2 (en) * 2004-06-24 2006-01-05 H. Lundbeck A/S The combination of an antipsychotic and a glycine transporter type i inhibitor for the treatment of schizophrenia
ES2520015T3 (es) * 2005-04-08 2014-11-11 Pfizer Products Inc. [3.1.0]Heteroaril amidas bicíclicas como inhibidores de transporte de glicina de tipo 1
GB0612420D0 (en) * 2006-06-22 2006-08-02 Glaxo Group Ltd Compounds
UA94615C2 (uk) * 2006-06-28 2011-05-25 Амген Інк. Інгібітори транспортера-1 гліцину

Also Published As

Publication number Publication date
TW201211019A (en) 2012-03-16
MX2013001166A (es) 2013-03-22
ES2521596T3 (es) 2014-11-13
ZA201300434B (en) 2013-09-25
PL2603219T3 (pl) 2015-03-31
EP2603219A1 (en) 2013-06-19
CL2013000378A1 (es) 2013-05-03
AU2011288536A1 (en) 2013-01-31
SI2603219T1 (sl) 2014-12-31
AR084401A1 (es) 2013-05-15
CY1115886T1 (el) 2017-01-25
CR20130027A (es) 2013-03-04
PE20131100A1 (es) 2013-09-23
KR101455947B1 (ko) 2014-10-28
MA34457B1 (fr) 2013-08-01
CN103068388A (zh) 2013-04-24
JP2013533297A (ja) 2013-08-22
NZ604891A (en) 2015-01-30
WO2012019970A1 (en) 2012-02-16
PH12013500078A1 (en) 2013-03-11
CA2803656A1 (en) 2012-02-16
KR20130045379A (ko) 2013-05-03
EP2603219B1 (en) 2014-09-17
ECSP13012431A (es) 2013-03-28
PT2603219E (pt) 2014-11-25
SG187108A1 (en) 2013-02-28
AU2011288536B2 (en) 2014-10-09
EA201291477A1 (ru) 2013-06-28
BR112013003068A2 (pt) 2016-06-28
US20120035156A1 (en) 2012-02-09
HRP20141199T1 (hr) 2015-02-13

Similar Documents

Publication Publication Date Title
DK2603219T3 (da) Kombination af GLYT1-forbindelse med antipsykotika
HUS1900001I1 (hu) Transztiretin expressziójának módosítása
DK2540728T3 (da) Heterocyklisk forbindelse
DK2567524T3 (da) Reduktion af protokolspild
DK2552261T3 (da) Propfilter med proprum med aromakugle
DK2633007T3 (da) Produktion af regenererbar biobenzin
DK2526158T3 (da) Forbedret klæbemiddelsammensætning
BR112012031667A2 (pt) composição
IL225867B (en) Coelenterazine substrates
EP2675909A4 (en) GLUCOSYLSTEVIA COMPOSITION
EP2713762A4 (en) Stevia-COMPOSITION
DK2603232T3 (da) Stabile formuleringer af linaclotid
BR112012032683A2 (pt) composição
DK2555704T3 (da) Visning af hæmostatiske parametre
DK2633006T3 (da) Fremstilling af fornybart bio-destillat
DK2260873T3 (da) Pcylering af proteiner
LT2865271T (lt) Pagerinta kompozicija
DK2358714T3 (da) Alkylcyclohexylethere af dihydrotetraazabenzoazulener
EP2636704A4 (en) FILM FORMING COMPOSITION
BR112012032980A2 (pt) composição
EP2628769A4 (en) FILM FORMING COMPOSITION
SI2635269T1 (sl) Kombinacijski sestavek
BR112012026803A2 (pt) composto
BR112013010643A2 (pt) compostos heterocíclicos
PL2658531T3 (pl) Zastosowanie stabilizatorów glutamidowych